Brief: Chemomab Therapeutics Announces First Quarter 2022 Financial Results And Provides Corporate Update
12/05/2022 11:15
May 12 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS ANNOUNCES FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.02
Source text for Eikon: ID:nPn2G7GVpa
Further company coverage: CMMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update